Abstract Aims-To study the possible accumulation of p53 protein in inverted papilloma of the urinary bladder. Methods-Formalin fixed, paraffin wax embedded sections from 14 cases of inverted papilloma of the urinary bladder were studied retrospectively. Accumulation of p53 was detected by immunohistochemistry using a mouse monoclonal antibody directed against p53. p53 protein reactivity was scored as follows: 0 = 10%; 
Urothelial inverted papilloma is an uncommon benign tumour that may be mistaken for papillary transitional cell carcinoma. These two tumours can be difficult to differentiate on routine histological examination. While p53 gene mutations are common in transitional cell carcinomas of urinary bladder,'" their frequency in urothelial inverted papillomas is unknown. The aim of this study was to ascertain whether p53 protein is accumulated in inverted papillomas and whether it can be used to distinguish inverted papillomas from papillary transitional cell carcinoma.
The p53 gene encodes a 53 kDa nuclear phosphoprotein which acts as a tumour suppressor gene. 5 The wild-type p53 protein is associated with the control of the normal cell cycle, DNA repair and synthesis, cell differentiation, genomic plasticity, and apoptosis. ... i p53 positive cases was determined by counting 500 cells and the cases were divided into four categories as follows: 0 = < 10% of tumour cells positive; 1 = 10% to <30% positive; 2=30% to 50% positive; and 3= >50% positive.
Results
Fourteen inverted papillomas of the urinary bladder were studied. Eleven were from men and three from women (table). The mean age of the patients was 60 3 years (range 39 to 77 years). Three of the inverted papillomas (cases 2, 9 and I 1) were initially reported as papillary carcinoma, either grade I or II. All 14 patients underwent complete transurethral resection of the tumour. Recurrent disease has not been documented in any of these 14 cases. Follow up ranged from nine to 102 months (mean 46 months). One patient (case 7) was diagnosed with carcinoma of cervix one year after her tumour of the bladder was detected and underwent total hysterectomy and post-operative radiotherapy. She was also receiving chemotherapy for acute promyelocytic leukaemia.
p53 immunoreactivity was observed in the nuclei, but not in the cytoplasm, of the tumour cells ( figure) . Less 
